NYSE$HCA

HCA Holdings Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

HCA Healthcare's financial performance rebounded in the second quarter of 2021 as the effects of the pandemic moderated. Revenues, net income, and adjusted EBITDA increased compared to the prior year. The company raised its 2021 guidance.

HCA Healthcare reported strong second quarter 2021 results, with revenues increasing to $14.435 billion and net income attributable to HCA Healthcare, Inc. totaling $1.450 billion, or $4.36 per diluted share. The company raised its 2021 guidance for revenues, adjusted EBITDA, and EPS.

  • Revenues totaled $14.435 billion.
  • Net income attributable to HCA Healthcare, Inc. totaled $1.450 billion, or $4.36 per diluted share.
  • Adjusted EBITDA totaled $3.219 billion.
  • Cash flows from operating activities totaled $2.251 billion.

Headline financials

Total Revenue

-$14M

Previous: $11.1B-100.1%
EPS (adj)

$4.37

Previous: $3.23+35.3%
Admissions

532.0K

Previous: 453.0K+17.5%
Number of Hospitals

187

Previous: 186+0.5%
Licensed Beds at End of Period

49.7K

Previous: 49.4K+0.6%
Occupancy

68.1%

Previous: 50.3%+35.4%
Average Length of Stay (days)

4.943

Previous: 4.991-1.0%
Capital Expenditures

-$1.5B

Previous: -$1.6B+6.4%
Free Cash Flow

-$46M

Previous: -$519M+91.1%
Net Income

$1.45B

Previous: $1.08B+34.4%
Operating Income

-$2.61B

Previous: -$2.2B-18.7%
Gross Profit

-$14M

Previous: $9.32B-100.2%
Cash & Equivalents

$1.12B

Previous: $4.64B-75.9%
Total Assets

$48.2B

Previous: $48.7B-1.1%
Stock-Based Comp

$129M

Previous: $66M+95.5%

Revenue & EPS history

HCA · Revenue · Quarterly

-$14M

Q2 2021-100.1%vs Q2 2020
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Forward guidance

The 2021 guidance ranges for the year have been revised from our first quarter release and are as follows: Revenues $57.0 to $58.0 billion, Adjusted EBITDA $12.10 to $12.50 billion, EPS (diluted) $16.30 to $17.10 per diluted share, Capital Expenditures Approximately $3.7 billion

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

-0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+2.9%

Avg return

30 days after

47%

31 / 66 earnings

Positive

+16.1%

Q2 2020

Best reaction

-21.9%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.2%-8.3%-16.8%
Q4 2025+6.2%+3.4%+11.3%
Q3 2025+1.5%+6.4%+11.6%
Q2 2025+0.8%+3.1%+3.8%
Q1 2025-4.0%+1.1%+10.3%
Q4 2024-3.8%+0.7%-2.7%
Q3 2024-10.6%-9.5%-18.5%
Q2 2024+5.7%+9.0%+17.7%
Q1 2024-0.9%-1.5%+1.5%
Q4 2023+6.3%+7.9%+8.7%
Q3 2023-6.5%-6.5%+5.0%
Q2 2023-3.2%-2.9%-3.2%
Q1 2023+5.7%+2.7%+4.3%
Q4 2022-0.6%+2.6%-2.2%
Q3 2022+0.8%+4.3%+10.3%
Q2 2022+9.6%+12.9%+18.6%
Q1 2022-21.9%-21.2%-24.0%
Q4 2021-1.4%-1.1%+5.5%
Q3 2021-7.0%-5.6%-8.1%
Q2 2021+14.5%+14.2%+13.3%
Q1 2021+2.5%+0.7%+4.5%
Q4 2020+3.7%+5.9%+5.6%
Q3 2020-4.4%-9.3%+12.5%
Q2 2020+16.1%+14.6%+21.2%
Q1 2020-5.4%-2.4%-2.2%
Q4 2019+2.6%-2.0%-10.1%
Q3 2019+6.2%+5.3%+10.3%
Q2 2019-8.7%-13.0%-17.4%
Q1 2019-1.1%+0.2%-2.3%
Q4 2018+5.6%+6.1%+5.5%
Q3 2018+3.5%+4.2%+12.0%
Q2 2018+14.9%+14.7%+21.4%
Q1 2018+2.1%+1.9%+7.7%
Q4 2017+3.6%+2.1%+1.9%
Q3 2017+0.9%+0.3%+11.6%
Q2 2017-5.2%-6.6%-7.9%
Q1 2017-1.2%-0.4%-0.1%
Q4 2016+3.4%+5.7%+10.2%
Q3 2016-2.1%-4.5%-9.6%
Q2 2016-1.1%-3.8%-4.8%
Q1 2016-1.7%
Q4 2015+3.1%
Q3 2015-0.1%
Q2 2015-2.8%
Q1 2015-1.2%
Q4 2014-1.7%
Q3 2014-2.1%
Q2 2014+4.1%
Q1 2014-1.2%
Q4 2013-1.0%
Q3 2013-5.1%
Q2 2013+0.1%
Q1 2013+3.8%
Q4 2012-1.1%
Q3 2012+8.0%
Q2 2012+1.1%
Q1 2012-1.1%
Q4 2009+3.5%
Q4 2011+3.5%
Q3 2011+2.6%
Q3 2010+2.6%
Q2 2011-20.6%
Q2 2010-20.6%
Q1 2011-0.2%
Q1 2010-0.2%
Q4 2010-0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro